Is cholesterol usually elevated in people over 90? find the research Use a Hierarchy of…
- User
Is cholesterol usually elevated in people over 90? find the research Use a Hierarchy of Evidence - This model ranks different types of scientific evidence based on their methodological rigor and potential for bias. Evidence quality is generally considered highest at the top of the pyramid and decreases towards the bottom. (Highest Quality / Well-Supported) • 1. Systematic Review: Comprehensive review of all relevant studies on a particular topic, using systematic methods to minimize bias. Often includes meta-analysis. • 2. Meta Analysis: Statistical technique for combining the findings from multiple independent studies to derive a single, more precise estimate of effect. (Supported) • 3. Randomized Controlled Trial (RCT): Experimental study where participants are randomly assigned to receive an intervention or a control/placebo. Considered the gold standard for evaluating intervention effectiveness. • 4. Cohort Study: Observational study following a group (cohort) over time to see how exposures affect outcomes. Can be prospective or retrospective. • 5. Case Control Study: Observational study comparing individuals with a specific condition/outcome (cases) to those without (controls) to identify past exposures or risk factors. • 6. Case Report / Case Series: Descriptive report of observations on a single patient (case report) or a small group of patients (case series). (Lowest Quality / Promising / Foundational) • 7. Expert Opinion / Background Information: Based on the experience and judgment of experts in the field, or general background knowledge. Lacks rigorous methodology. Key Dimensions: • Quality: Increases as you move up ( 7 to 1 ) • Level of Support: Generally progresses from "Promising" at the base, through "Supported" for observational and experimental studies, to "Well-Supported" for syntheses like systematic reviews and meta-analyses. Essence: The model illustrates that not all evidence is equal. When making decisions (especially in fields like medicine or policy), evidence from higher up the pyramid (like Systematic Reviews or RCTs) is generally more reliable and should be given more weight than evidence from lower down (like Case Reports or Expert Opinion).
Assistant
Hierarchy of Evidence Summary
To answer whether cholesterol is usually elevated in people over 90, we review evidence from the top of the hierarchy (systematic reviews and meta-analyses), followed by large cohort studies and cross-sectional analyses. The focus is on total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C), the most clinically relevant measures.
Systematic Reviews and Meta-Analyses
-
Systematic Review of Cohort Studies (BMJ Open, 2016):
This review included 19 cohort studies (68,094 participants, all ≥60 years). It found that high LDL-C was inversely associated with mortality in most elderly people, meaning higher LDL-C was linked to lower mortality. Importantly, the association between cholesterol and mortality weakened with age and became minimal after age 80. The review concluded that high LDL-C is not a risk factor for mortality in the elderly, and in some cases, lower LDL-C was associated with higher mortality[9][11]. -
Meta-Analysis of Statin Trials in Older Adults:
A systematic review and meta-analysis of randomized controlled trials found that lowering LDL-C in patients aged 75 and older reduced cardiovascular events, but did not specifically address whether cholesterol is elevated in the oldest old. The benefit of statins was consistent, but the relationship between baseline cholesterol and mortality was not direct in the very old[12][15].
Large Cohort and Cross-Sectional Studies
-
Centenarian Studies (Ages 99–109):
Multiple cohort and cross-sectional studies consistently report that centenarians (people aged 100+) have lower total cholesterol and LDL-C compared to younger elderly controls (typically aged 70–80). For example, a study of Chinese centenarians found average TC of 3.90 mmol/L and LDL-C of 2.05 mmol/L, both lower than in younger elderly populations. The prevalence of dyslipidemia (abnormal cholesterol) was also lower in centenarians[2][4][14]. -
Swedish Longitudinal Study (GeroScience, 2023):
In a study of over 44,500 Swedes followed from age 64–99, those who became centenarians tended to have higher total cholesterol in their 60s and 70s compared to peers who did not reach 100. However, by the time people reached extreme old age, cholesterol levels were not markedly elevated, and centenarians seldom had extremely high or low cholesterol values. The differences, while statistically significant, were small in absolute terms[5][8]. -
Jerusalem Longitudinal Cohort (Ages 70–90):
The prevalence of high TC (>200 mg/dL) dropped from 75% at age 70 to 34% at age 85. Cholesterol levels were unrelated to mortality between ages 70 and 90, and statin use was associated with lower mortality, independent of cholesterol levels[16]. -
Hainan Centenarian Study:
Among 1,002 centenarians, only 7% had hypercholesterolemia. Median TC was lower than in younger controls, and the majority of centenarians had cholesterol within or below the normal range[14].
Key Findings from the Evidence Hierarchy
Evidence Type Finding on Cholesterol in 90+ Population Source(s) Systematic Review/Meta-Analysis High LDL-C not associated with increased mortality; often lower in oldest old [9][11] Large Cohort Studies Centenarians have lower TC and LDL-C than younger elderly [2][4][14][16] Longitudinal Studies Higher cholesterol in midlife may predict longevity, but not elevated in extreme old age [5][8] Cross-sectional Studies Prevalence of high cholesterol is low in centenarians [2][14]
Interpretation
- Cholesterol levels (both total and LDL-C) tend to decrease with advanced age, especially after age 80.
- Centenarians and people over 90 generally have lower, not higher, cholesterol compared to younger elderly cohorts.
- The prevalence of hypercholesterolemia is low among centenarians.
- High cholesterol in midlife may be associated with reaching old age, but by the time people reach 90+, their cholesterol is typically not elevated.
- The relationship between cholesterol and mortality risk weakens with age and may even reverse in the oldest old.
Conclusion
Cholesterol is not usually elevated in people over 90.
Most high-quality evidence, including systematic reviews and large cohort studies, shows that total cholesterol and LDL-C levels decrease in the oldest old, and centenarians typically have lower cholesterol than younger elderly individuals[2][4][9][11][14][16]. The prevalence of high cholesterol is low in this age group, and the clinical significance of cholesterol as a risk factor for mortality diminishes with age.-
- User
Did any study include life long cholesterol measurements so taht we might figure out of those elderly with high LDL probably had very strong hearts or cardiovasculat systems that explained the effect or maybe straight explaiantions of this paradox? Cholesterol paradox.
Assistant
Did Any Study Include Lifelong Cholesterol Measurements to Explain the Cholesterol Paradox in the Elderly?
Systematic Reviews and Longitudinal Cohorts
1. Lifelong Cholesterol Trajectories and the Paradox
- The Framingham Heart Study and other large cohorts have tracked cholesterol from midlife through late life. These studies consistently show that total cholesterol and LDL-C rise through midlife, then decline in later years, especially after age 70–75[1][3][4].
- The decline in cholesterol in late life is only partially explained by weight loss, dietary changes, or medication. Even after adjusting for these, cholesterol levels still drop with age, suggesting additional biological factors[1][3].
2. Cumulative LDL-C Exposure and Cardiovascular Risk
- The CARDIA study and other longitudinal analyses have shown that cumulative LDL-C exposure (the area under the LDL-C vs. age curve) is a strong predictor of cardiovascular events[10]. The risk is highest when high LDL-C is present earlier in life, and the same cumulative exposure at a younger age confers more risk than if it occurs later[10].
- This means that elderly people with high LDL-C who reach advanced age without cardiovascular events may represent a "survivor" group with inherently resilient cardiovascular systems or favorable genetics[1][10].
3. The Cholesterol Paradox in the Oldest Old
- Multiple studies, including a recent Sardinian longevity cohort, confirm the "cholesterol paradox": in people over 90, higher LDL-C is not associated with increased mortality and may even be linked to longer survival[12][11].
- These findings are unlikely to be fully explained by reverse causality (i.e., low cholesterol as a marker of illness), as studies have excluded those with terminal illness and early deaths, and the paradox persists[12].
- Some explanations include:
- Survivor bias: Only those with robust cardiovascular systems survive to old age despite high LDL-C[1][12].
- Changes in cholesterol metabolism: Aging may alter cholesterol handling, reducing its atherogenic potential[12][15].
- Inflammation and nutrition: Low cholesterol in the elderly can reflect malnutrition or chronic disease, which are themselves risk factors for mortality[15].
4. Genetic and Biological Modifiers
- Genetic factors, such as APOE allele status, modulate cholesterol trajectories and may partly explain why some individuals tolerate higher cholesterol without adverse outcomes[1].
- The Sardinian study found that even after excluding those with diabetes or poor health, the cholesterol paradox remained, suggesting that robust cardiovascular or metabolic health may underlie the phenomenon[12].
Summary Table: Evidence on Lifelong Cholesterol and the Paradox
Study Type / Source Lifelong Cholesterol Data? Key Findings on Paradox and Explanations Framingham Heart Study[1] Yes (midlife to late life) Cholesterol rises then falls; survivor bias likely Rancho Bernardo Study[3] Yes (8-year follow-up) Cholesterol drops in old age, not fully explained by weight or meds CARDIA Study[10] Yes (decades-long) Cumulative LDL-C exposure predicts CVD; early exposure riskier Sardinia Longevity Cohort[12] Yes (nonagenarians) Higher LDL-C linked to longer survival; paradox persists after excluding sick/frail Systematic Review (Ravnskov)[12] Yes (multiple cohorts) Paradox not explained by reverse causality alone Conclusions
- Yes, several high-quality longitudinal studies have tracked cholesterol over the lifespan.
- These studies show that people who reach very old age with high LDL-C likely have inherently strong cardiovascular systems or protective genetic/biological factors.
- The cholesterol paradox in the elderly is not fully explained by reverse causality or measurement timing. Survivor bias, altered cholesterol metabolism, and the role of inflammation and nutrition are leading explanations[1][10][12][15].
- Cumulative LDL-C exposure is a key determinant of cardiovascular risk, but those who survive to advanced age with high LDL-C are a select, resilient group.
In summary: Lifelong cholesterol data support the view that the cholesterol paradox in the oldest old is largely due to survivor bias and biological resilience, not that high LDL-C is harmless for everyone[1][10][12][15].
- User
but ApoB is low in those with high overall cholesterol? The elderly I mean.
Assistant
ApoB and High Cholesterol in the Elderly: What Does the Evidence Show?
Key Findings from High-Quality Evidence
-
ApoB, LDL-C, and Total Cholesterol Trends with Age
- Both ApoB and LDL-C levels tend to decrease as people age, especially after age 70[1][11].
- In elderly populations, including those over 70, average ApoB levels are lower than in younger adults, even among those with higher total cholesterol or LDL-C[1][11].
- The risk associated with elevated ApoB, LDL-C, or total cholesterol is much greater in younger individuals and declines with age[1][6][11].
-
Discordance Between ApoB and LDL-C
- While ApoB, LDL-C, and non-HDL-C are usually correlated, there can be discordance: some individuals may have high LDL-C but not high ApoB, and vice versa[3][7][9].
- In the elderly, it is possible—but not common—for someone to have high total cholesterol or LDL-C with relatively low ApoB. This typically reflects larger, cholesterol-rich LDL particles, which are less atherogenic than small, dense LDL particles[3][9].
- Conversely, some elderly may have normal or even low LDL-C but elevated ApoB, indicating a higher number of small, dense, atherogenic particles[3][9].
-
ApoB as a Predictor of Risk in the Elderly
- ApoB remains a better predictor of cardiovascular risk than LDL-C or total cholesterol at any age, but its predictive power for events diminishes in the oldest old[1][6][11].
- High ApoB is associated with increased cardiovascular risk and mortality up to about age 80, but this association weakens or disappears in those over 80[6].
- In very old adults, low ApoB (and low cholesterol) can be a marker of frailty, malnutrition, or underlying illness, which may explain paradoxical findings where low ApoB is linked to higher mortality in some studies[8].
Summary Table: ApoB and Cholesterol in the Elderly
Marker Trend with Age Can It Be High When Cholesterol Is High? Risk Implications in Elderly ApoB Decreases Usually tracks with cholesterol, but discordance possible; high cholesterol with low ApoB is uncommon and usually means larger, less atherogenic LDL particles[3][9] High ApoB predicts risk up to ~80, less so after[1][6][11] LDL-C/Total Cholesterol Decreases Can be high with low ApoB (large LDL particles), but more often high ApoB accompanies high cholesterol[3][9] Risk association weakens with age[1][6][11] Clinical and Physiological Interpretation
- In the elderly, high total cholesterol does not usually occur with low ApoB. When it does, it suggests the cholesterol is carried in fewer, larger LDL particles, which are less atherogenic[3][9].
- ApoB is the best marker of atherogenic particle number. If ApoB is low, even with high cholesterol, the number of atherogenic particles is not elevated, and cardiovascular risk is lower than cholesterol alone would suggest[3][9].
- Discordance is uncommon but clinically relevant. Measuring ApoB can clarify risk, especially in elderly patients with unusual lipid profiles[3][7][9].
- In advanced age, both cholesterol and ApoB levels tend to fall, and the predictive value of these markers for mortality diminishes. Low levels may reflect frailty or illness rather than protection from cardiovascular disease[6][8][11].
Bottom Line
In elderly individuals, high overall cholesterol is usually accompanied by high ApoB, but both tend to decrease with age. When high cholesterol occurs with low ApoB, it is uncommon and typically reflects a less atherogenic lipid profile. ApoB remains a superior risk marker, but its predictive value for mortality lessens in the oldest old, and low ApoB in this group can also signal poor health or malnutrition rather than low cardiovascular risk[1][3][6][8][9][11].
-
- User
what about small and big molecule LDL?
Assistant
Small vs. Large LDL Particles: What’s the Difference and Why Does It Matter, Especially in the Elderly?
LDL Particle Types
- Large, Buoyant LDL (lbLDL):
These are bigger, less dense, and “fluffy” particles. They are less likely to penetrate the arterial wall and are cleared more efficiently by the liver[1][4][7][17]. - Small, Dense LDL (sdLDL):
These are smaller, denser, and “stickier” particles. They are more likely to penetrate the arterial wall, become oxidized, and trigger atherosclerosis. They also remain in circulation longer because they have lower affinity for LDL receptors[1][4][12][17].
Atherogenicity (Risk for Heart Disease)
- Small, Dense LDL:
- Strongly associated with increased risk of atherosclerosis and cardiovascular disease[1][2][4][12][13][14][17].
- More easily enters the arterial wall and is more susceptible to oxidation, which promotes plaque formation[1][12][17].
- Elevated in conditions like diabetes, metabolic syndrome, and high triglycerides[1][2][4][12][15].
- Large, Buoyant LDL:
- Less atherogenic and less likely to cause heart disease[1][4][7][17].
- More easily cleared from the bloodstream.
LDL Particle Size and Risk in the Elderly
- Younger and Middle-Aged Adults:
- Numerous studies show that a predominance of small, dense LDL is a strong, independent risk factor for coronary heart disease[1][2][4][12][13][14][17].
- Elderly (65+):
- The relationship between LDL size and heart disease risk becomes less clear with age.
- A large prospective study in elderly adults (65–74 years) found that LDL size was not a significant predictor of coronary heart disease after adjusting for diabetes and other risk factors. Instead, ApoB, total cholesterol/HDL ratio, and blood pressure were stronger predictors[6][8].
- Survival bias may play a role: those most susceptible to the harms of small, dense LDL may not survive into old age, so the remaining elderly population may be less affected by LDL particle size[6][8].
Clinical Implications
- ApoB vs. LDL Size:
- ApoB (which counts the number of atherogenic particles) is a better predictor of risk than LDL size alone, especially in the elderly[5][6][10][11].
- Small, dense LDL is most dangerous when ApoB is also elevated[13].
- Testing:
- Standard cholesterol tests do not distinguish between small and large LDL. Specialized tests (NMR, gradient gel electrophoresis) are needed to assess particle size[4][16].
- Routine testing for LDL size is not recommended for everyone, but may be useful in those with metabolic syndrome, diabetes, or unexplained heart disease risk[2][14].
Summary Table: Small vs. Large LDL
Feature Small, Dense LDL (sdLDL) Large, Buoyant LDL (lbLDL) Size ≤25.5 nm >25.5 nm Density High Low Atherogenicity High Low Clearance by Liver Poor Efficient Associated Conditions Diabetes, Metabolic Syndrome, High TG Fewer associations Risk in Elderly Less predictive Less relevant Best Risk Marker ApoB ApoB Key Takeaways
- Small, dense LDL is more atherogenic than large, buoyant LDL, especially in younger and middle-aged adults[1][2][4][12][13][14][17].
- In the elderly, LDL particle size is less predictive of heart disease risk; ApoB and other classic risk factors become more important[6][8][10][11].
- Measuring ApoB provides a more accurate assessment of cardiovascular risk than focusing on LDL size alone, particularly in older adults[5][6][10][11][13].
In summary, while small, dense LDL is more dangerous than large, buoyant LDL, especially for younger people, its predictive value for heart disease diminishes in the elderly, where ApoB and other risk factors take precedence.
- Large, Buoyant LDL (lbLDL):
Other models, same or similar prompt
Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.